Ekso Bionics (EKSO) CFO Wong sells $5,818 in stock
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ekso Bionics Holdings Inc (EKSO)
Assess today's live Ekso Bionics Holdings Inc (EKSO) share price, performance and insights using our live NASDAQ: EKSO stock exchange data.
Analyse the historical data and Ekso Bionics Holdings Inc share price performance charts on this page. Our technical summary section provides analysis on Ekso Bionics share price buy/sell indicators using real-time data (or discuss the Ekso Bionics (EKSO) stock price today with other investors in the Ekso Bionics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ EKSO share price (ISIN: US2826444000) to enhance your trading decisions with our free investment tools and resources.
What Is the Ekso Bionics Holdings Inc Share Price Today?
The Ekso Bionics share price today is 5.310.
What Is the Stock Symbol for Ekso Bionics Holdings Inc
The stock symbol (or 'ticker') for Ekso Bionics Holdings Inc is "EKSO."
What Stock Exchange Does Ekso Bionics Holdings Inc Trade On?
Ekso Bionics Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Ekso Bionics Holdings Inc a Good Stock to Buy?
Determining whether Ekso Bionics Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Ekso Bionics Holdings Inc share price performance charts on this page. Our technical summary section provides analysis on Ekso Bionics share price buy/sell indicators using real-time data (or discuss the Ekso Bionics (EKSO) stock price today with other investors in the Ekso Bionics NASDAQ share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NASDAQ EKSO share price (ISIN: US2826444000) to enhance your trading decisions with our free investment tools and resources.
What Is the Ekso Bionics Holdings Inc Share Price Today?
The Ekso Bionics share price today is 5.310.
What Is the Stock Symbol for Ekso Bionics Holdings Inc
The stock symbol (or 'ticker') for Ekso Bionics Holdings Inc is "EKSO."
What Stock Exchange Does Ekso Bionics Holdings Inc Trade On?
Ekso Bionics Holdings Inc is listed and trades on the NASDAQ stock exchange.
Is Ekso Bionics Holdings Inc a Good Stock to Buy?
Determining whether Ekso Bionics Holdings Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.080
5.400
52 wk Range
2.730
14.975
EKSO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.0805.400
52 wk Range
2.73014.975
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
EKSO Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
7.750
Upside
+45.95%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
- Ekso Bionics (EKSO) COO Jones sells $1269 in stock
- Investing.com
- Ekso Bionics (EKSO) CFO Wong sells $5,818 in stock
- Investing.com
- Ekso Bionics (EKSO) COO Jones sells $1269 in stock
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Ekso Bionics Company Profile
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EVO, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. It also offers EksoCare offering an extended warranty and premium service options, repairs and maintenance services, and training programs. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
Ekso Bionics Holdings Inc Earnings Call Summary for Q2/2025
- Ekso Bionics reported Q2 2025 revenue of $2.1M, down 58% YoY, with EPS of -$0.54 missing forecasts of -$0.085; stock rose 6.71% to $5.25 despite the earnings miss.
- The company posted a net loss of $2.7M ($1.24 per share) with gross profit of $800K (40% margin); cash position stands at $5.2M as of June 30, 2025.
- Personal health sector showed over 50% YTD growth; company forecasts it will surpass enterprise health revenues by 2027, with plans to close $1.4M in deferred sales.
- CEO Scott Davis emphasized AI integration as 'necessary for broader adoption of exoskeletons' and highlighted positive outcomes in securing Medicare reimbursements.
- Key challenges include federal grant uncertainties affecting enterprise health revenue, dependence on budget conversions, and potential delays in closing deferred sales.
Last Updated: 20/11/2025, 15:34
Read Full TranscriptCompare EKSO to Peers and Sector
Metrics to compare | EKSO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipEKSOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.7x | −9.6x | −0.6x | |
PEG Ratio | −0.04 | −0.17 | 0.00 | |
Price/Book | 1.9x | 4.0x | 2.6x | |
Price / LTM Sales | 1.2x | 3.3x | 3.2x | |
Upside (Analyst Target) | 46.0% | 49.5% | 41.8% | |
Fair Value Upside | Unlock | 3.4% | 5.1% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 7.750
(+45.95% Upside)
Earnings
Latest Release
Oct 28, 2025
EPS / Forecast
-0.54 / -0.085
Revenue / Forecast
4.23M / 5.17M
People Also Watch
FAQ
What Is the Ekso Bionics (EKSO) Share Price Today?
The live Ekso Bionics share price today is 5.310
What Stock Exchange Does Ekso Bionics (EKSO) Trade On?
Ekso Bionics is listed and trades on the Nasdaq Stock Exchange.
What Is the Ticker (Stock Symbol) for Ekso Bionics?
The stock symbol (also called a 'ticker') for Ekso Bionics is "EKSO."
What Is the Current Ekso Bionics Market Cap?
As of today, Ekso Bionics market capitalisation is 18.02M.
What Is Ekso Bionics's (EKSO) Earnings Per Share (TTM)?
The Ekso Bionics EPS is currently -5.24 (Trailing Twelve Months).
Is EKSO a Buy or Sell From a Technical Analyst Perspective?
Based on today's Ekso Bionics moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Ekso Bionics Stock Split?
Ekso Bionics has split 4 times. (See the EKSO stock split history page for full effective split date and price information.)
How Many Employees Does Ekso Bionics Have?
Ekso Bionics has 64 employees.
What is the current trading status of Ekso Bionics (EKSO)?
As of 24 Dec 2025, Ekso Bionics (EKSO) is trading at a price of 5.310, with a previous close of 5.270. The stock has fluctuated within a day range of 5.080 to 5.400, while its 52-week range spans from 2.730 to 14.975.
What Is Ekso Bionics (EKSO) Price Target According to Analysts?
The average 12-month price target for Ekso Bionics is USD7.75, with a high estimate of USD9.5 and a low estimate of USD6. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +45.95% Upside potential.
What Is the EKSO After Hours Price?
EKSO's last after hours stock price is 5.300, the stock has decreased by -0.010, or -0.190%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.